Flume Health
We're Hiring!
Flume Health Company Growth, Stability & Outlook
What People Are Saying About Flume Health
-
Investor Backing & Capital Strength: Investor backing from a $30M Series A in March 2022 led by Optum Ventures with participation from Cigna Ventures provides runway for a small team. Signals suggest this capital supports measured execution in the absence of newer disclosed rounds.
-
Product Line Growth: Ongoing product/content updates in 2026 and prior launch of Flume Relay indicate active development of the healthcare iPaaS offering. Recent case‑style posts and refreshed documentation point to continued platform maturation.
-
Future-Ready Strategy: The October 2023 divestiture of TPA operations to focus on a payer data/integration platform concentrates resources on scalable software. Positioning around canonical data models, interoperability (EDI/FHIR), and automation aligns with evolving payer needs.
